Regulatory lanes
Six ways a product can be made, and what each one means for your practice. Pricing unlocks with your NPI — understanding does not.
Made for one named patient, by a licensed compounding pharmacy. Not for office stock.
Prescribed in your portalOpen lane →503B OutsourcingNo patient neededOffice stock, no patient name neededBatch-made by an FDA-registered outsourcing facility. This is what legitimate office stock runs on.
Sign in to see listingsOpen lane →PUONo patient neededProfessional use onlyA supplier trade term for professional use. It confers no approved-product status.
Sign in to see listingsOpen lane →CosmeticNo patient neededAppearance, not treatmentNo premarket approval — but a drug claim reclassifies it as a drug, whatever the label says.
69 productsOpen lane →Biologic — AcellularNo patient neededHCT/P, no living cellsAcellular HCT/Ps under Part 1271. Section 361 or 351 turns on manipulation and use.
Sign in to see listingsOpen lane →Biologic — CellularNo patient neededLiving cells — highest scrutinyLiving cells. Usually a section 351 biologic needing an approved BLA or an active IND.
Sign in to see listingsOpen lane →Lane summaries are educational orientation, not legal advice. Confirm any classification against current FDA guidance and your state board before you order.
Real screens from the MedGrid portal, shown with demo accounts and sample data.
Join free: we check your NPI at signup, then each lane's shelves and wholesale pricing open.
Put a lane to work.
Legal resource center
The federal floor for each product class, and what your state adds before you order into it.
Choose a pharmacy
Compounding pharmacies and outsourcing facilities, with the class they fill and where they are licensed.
Product finder
Two picks: the category, then the vendor that carries it.
